Journal article · 2024 · Open access

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021

Catherine Bakari, Celine I. Mandara, Rashid A. Madebe, Misago D. Seth, Billy Ngasala, Erasmus Kamugisha, Maimuna Ahmed, Filbert T. Francis, Samwel Bushukatale, Mercy Grace Chiduo, Twilumba Makene, Abdunoor M. Kabanywanyi and 23 more

Malaria Journal, 23(1), 71 · Published 9 March 2024 · DOI 10.1186/s12936-024-04896-0

Open full textCite this paper

In brief

“Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021” is a 2024 journal article by Catherine Bakari and 34 co-authors, published in Malaria Journal. OpenAlex counts 28 citations as of 19 November 2026, which puts it in the top 6% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Malaria Journal.

Citations
28
Most cited in
2026 (14)
Field-weighted impact
7.56
References
34
Authors
35

Abstract

BACKGROUND: Therapeutic efficacy studies (TESs) and detection of molecular markers of drug resistance are recommended by the World Health Organization (WHO) to monitor the efficacy of artemisinin-based combination therapy (ACT). This study assessed the trends of molecular markers of artemisinin resistance and/or reduced susceptibility to lumefantrine using samples collected in TES conducted in Mainland Tanzania from 2016 to 2021. METHODS: A total of 2,015 samples were collected during TES of artemether-lumefantrine at eight sentinel sites (in Kigoma, Mbeya, Morogoro, Mtwara, Mwanza, Pwani, Tabora, and Tanga regions) between 2016 and 2021. Photo-induced electron transfer polymerase chain reaction (PET-PCR) was used to confirm presence of malaria parasites before capillary sequencing, which targeted two genes: Plasmodium falciparum kelch 13 propeller domain (k13) and P. falciparum multidrug resistance 1 (pfmdr1). RESULTS: Sequencing success was ≥ 87.8%, and 1,724/1,769 (97.5%) k13 wild-type samples were detected. Thirty-seven (2.1%) samples had synonymous mutations and only eight (0.4%) had non-synonymous mutations in the k13 gene; seven of these were not validated by the WHO as molecular markers of resistance. One sample from Morogoro in 2020 had a k13 R622I mutation, which is a validated marker of artemisinin partial resistance. For pfmdr1, all except two samples carried N86 (wild-type), while mutations at Y184F increased from 33.9% in 2016 to about 60.5% in 2021, and only four samples (0.2%) had D1246Y mutations. pfmdr1 haplotypes were reported in 1,711 samples, with 985 (57.6%) NYD, 720 (42.1%) NFD, and six (0.4%) carrying minor haplotypes (three with NYY, 0.2%; YFD in two, 0.1%; and NFY in one sample, 0.1%). Between 2016 and 2021, NYD decreased from 66.1% to 45.2%, while NFD increased from 38.5% to 54.7%. CONCLUSION: This is the first report of the R622I (k13 validated mutation) in Tanzania. N86 and D1246 were nearly fixed, while increases in Y184F mutations and NFD haplotype were observed between 2016 and 2021. Despite the reports of artemisinin partial resistance in Rwanda and Uganda, this study did not report any other validated mutations in these study sites in Tanzania apart from R622I suggesting that intensified surveillance is urgently needed to monitor trends of drug resistance markers and their impact on the performance of ACT.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bakari, C., Mandara, C. I., Madebe, R. A., Seth, M. D., Ngasala, B., Kamugisha, E., Ahmed, M., Francis, F. T., Bushukatale, S., Chiduo, M. G., Makene, T., Kabanywanyi, A. M., Mahende, M. K., Kavishe, R. A., Muro, F. J., Mkude, S., Mandike, R., Molteni, F., Chacky, F., . . . Ishengoma, D. S. (2024). Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021. Malaria Journal, 23(1), 71. https://doi.org/10.1186/s12936-024-04896-0

MLA 9

Bakari, Catherine, et al. “Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.” Malaria Journal, vol. 23, no. 1, 2024, p. 71. https://doi.org/10.1186/s12936-024-04896-0.

Chicago

Bakari, Catherine, Celine I. Mandara, Rashid A. Madebe, Misago D. Seth, Billy Ngasala, Erasmus Kamugisha, Maimuna Ahmed, et al. 2024. “Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.” Malaria Journal 23 (1): 71. https://doi.org/10.1186/s12936-024-04896-0.

Harvard

Bakari, C. et al. (2024) ‘Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021’, Malaria Journal, 23(1), p. 71. doi:10.1186/s12936-024-04896-0.

IEEE

C. Bakari et al., “Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021,” Malaria Journal, vol. 23, no. 1, p. 71, 2024, doi: 10.1186/s12936-024-04896-0.

BibTeX

@article{bakari2024trends,
  title     = {{Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021}},
  author    = {Bakari, Catherine and Mandara, Celine I. and Madebe, Rashid A. and Seth, Misago D. and Ngasala, Billy and Kamugisha, Erasmus and Ahmed, Maimuna and Francis, Filbert T. and Bushukatale, Samwel and Chiduo, Mercy Grace and Makene, Twilumba and Kabanywanyi, Abdunoor M. and Mahende, Muhidin Kassim and Kavishe, Reginald Adolph and Muro, Florida Joseph and Mkude, Sigsbert and Mandike, Renata and Molteni, Fabrizio and Chacky, Frank and Bishanga, Dunstan Raphael and Njau, Ritha and Warsame, Marian and Kabula, Bilali I. and Nyinondi, Ssanyu S. and Lucchi, Naomi W. and Talundzic, Eldin and Venkatesan, Meera and Moriarty, Leah F. and Serbantez, Naomi and Kitojo, Chonge A. and others},
  journal   = {Malaria Journal},
  year      = {2024},
  volume    = {23},
  number    = {1},
  pages     = {71},
  doi       = {10.1186/s12936-024-04896-0},
  url       = {https://doi.org/10.1186/s12936-024-04896-0}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202433
20251111
20261414

Its field-weighted citation impact is 7.56: it has been cited 7.56 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • Plasmodium falciparum
  • artemisinin resistance
  • pfmdr1
  • artemether-lumefantrine
  • artemisinin-based combination therapy
  • drug resistance markers
  • mainland Tanzania

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Bakari, C., Mandara, C. I., Madebe, R. A., Seth, M. D., Ngasala, B., Kamugisha, E., Ahmed, M., Francis, F. T., Bushukatale, S., Chiduo, M. G., Makene, T., Kabanywanyi, A. M., Mahende, M. K., Kavishe, R. A., Muro, F. J., Mkude, S., Mandike, R., Molteni, F., Chacky, F., . . . Ishengoma, D. S. (2024). Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021. Malaria Journal, 23(1), 71. https://doi.org/10.1186/s12936-024-04896-0

How many times has this paper been cited?

28 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Malaria Journal: sign in and open the full text from this page.

Who wrote this paper?

Catherine Bakari, Celine I. Mandara, Rashid A. Madebe, Misago D. Seth, Billy Ngasala, Erasmus Kamugisha, Maimuna Ahmed, Filbert T. Francis, Samwel Bushukatale, Mercy Grace Chiduo, Twilumba Makene, Abdunoor M. Kabanywanyi and 23 more.

What is the DOI of this paper?

10.1186/s12936-024-04896-0, permanently at https://doi.org/10.1186/s12936-024-04896-0. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.